Natera Announces Fourth Quarter and Fiscal 2023 Earnings Conference Call
- None.
- None.
Earnings Conference Call Information:
Event: |
Natera’s Fourth Quarter and Year-End 2023 Financial Results |
|
Date: |
Wednesday, Feb. 28, 2024 |
|
Time: |
1:30 p.m. PT (4:30 p.m. ET) |
|
Live Dial-In:
|
1 (888) 770-7321 (Domestic)
|
|
Conference ID: |
7684785 |
|
Webcast: |
||
A webcast replay will be available at investor.natera.com. |
About Natera
Natera™ is a global leader in cell-free DNA testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 180 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240220780446/en/
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com
Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com
Source: Natera, Inc.
FAQ
When will Natera, Inc. (NTRA) release its Q4 and year-end 2023 financial results?
What time will the conference call and webcast take place for Natera, Inc. (NTRA)'s financial results?